US FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNTnRScXF6U1QyYm9qejFheHhZajVzb2dIZTRhcjJLV0R2TGJ5bUZpQU84Sm9JRkEyN2VzWFNlS2R3SExtN2cwTk9ZeDZ2ZEtYSGNIaWpndDRGY09IQ2JqY21Ia2kzbmp1djRyMVlBZHFvaEVOY0VlSGdhQmFVLURBcGMxdk1qaUVSOENxb2dKcFhleHRQcnBtN1ZRQmlBOVcyZktIZC1RQmVGWGRZZ3FJekg2anNEYmVmMGc?oc=5" target="_blank">US FDA approves Mirum's drug for rare bone disorder</a> <font color="#6f6f6f">reuters.com</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMUS FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMTrump's FDA pick to face vaccine, abortion pill questions at US Senate hearing - Reuters
Trump's FDA pick to face vaccine, abortion pill questions at US Senate hearing Reuters
September 24, 2026 at 10:24 AMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMViking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters
September 22, 2026 at 08:10 PM